Literature DB >> 2663282

Magnetic resonance imaging of musculoskeletal neoplasms.

T H Berquist1.   

Abstract

Magnetic resonance imaging (MRI) has become a valuable technique in the evaluation of the musculoskeletal system. Its superior soft-tissue contrast and its ability to image in multiple planes provide significant advantages over other imaging techniques, including computed tomography. MRI has been particularly useful in the detection and staging of musculoskeletal neoplasms. Currently, it is the technique of choice for the evaluation of soft-tissue masses and many skeletal neoplasms. MRI is also useful in the evaluation of metastasis. The role of MRI in differentiating recurrent neoplasms from postoperative and radiation changes continues to evolve; spectroscopy may add considerable specificity in this setting.

Entities:  

Mesh:

Year:  1989        PMID: 2663282

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  Magnetic resonance imaging of peripheral soft tissue hemangiomas.

Authors:  M C Nelson; M A Stull; G P Teitelbaum; R H Patt; E E Lack; G P Bogumill; M T Freedman
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

Review 2.  Soft-tissue masses in the shoulder girdle: an imaging perspective.

Authors:  Srinivasan Harish; Asif Saifuddin; Philip W P Bearcroft
Journal:  Eur Radiol       Date:  2006-04-25       Impact factor: 5.315

Review 3.  Radiological detection of bone and bone marrow metastases.

Authors:  H Jacobsson; H Göransson
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

4.  View-Angle Tilting and Slice-Encoding Metal Artifact Correction for Artifact Reduction in MRI: Experimental Sequence Optimization for Orthopaedic Tumor Endoprostheses and Clinical Application.

Authors:  Pia M Jungmann; Carl Ganter; Christoph J Schaeffeler; Jan S Bauer; Thomas Baum; Reinhard Meier; Mathias Nittka; Florian Pohlig; Hans Rechl; Ruediger von Eisenhart-Rothe; Ernst J Rummeny; Klaus Woertler
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.